Medical Cannabis to Boost Exports for Colombia

Medical cannabis will generate more than 1.7 billion dollars and thousands of jobs. That’s what Colombia expects its new framework will contribute to its economy between now and 2030, boosting the country’s exports. To give some perspective, the $1.7 billion figure is even higher than that of foreign sales of flowers, one of its flagship products, according to official sources.

Keep up to date with all the latest regulatory and commercialization events by downloading our free companion Hemp.im cannabis news app.

Medical Cannabis Will Diversify Colombia’s Economy

“Within the framework of the secure economic reactivation, this industry represents a viable alternative for the diversification of Colombian exports and the reduction of dependence on traditional sectors,” said the president of ProColombia, Flavia Santoro, quoted in a statement from her office.

Australia, the United Kingdom, the United States, Peru, Ecuador, Brazil, and some European Union countries are the destinations with the greatest potential for international medical cannabis sales for Colombia.

The sector “represents concrete export opportunities, generation of formal jobs, and investment in science and technology,” added Santoro.

According to ProColombia, so far 18 foreign investment projects for 288 million dollars have arrived. This has created more than 2 thousand jobs at including such as Khiron, PharmaCielo, and Avicanna, among others, according to reports from businessmen to this state entity.

“From ProColombia, we will continue to accompany foreign investors and exporters so that their businesses reach a good port,” said Santoro.

Medical Cannabis Will Drive Job creation

According to ProColombia’s calculations, which propose a scenario of intermediate international prices for medical cannabis of 2,000 dollars per kilogram of extract, it is estimated that 44,000 jobs will be generated by this industry in 2030.

To date, licenses for the cultivation of psychoactive and non-psychoactive cannabis, seeds for sowing, and the manufacture of derivatives have been authorized in 32 municipalities in eleven departments of Colombia.

The country also has a supply of seeds, raw extracts, distillates, isolates, and finished products such as medicines and cosmetics.

On the other hand, between January and May of this year, exports of medical cannabis from Colombia totaled 2.2 million dollars, an increase of 0.6 percent over the same period last year, with the United Kingdom, Australia, the United States, and Israel as the main destinations.

An investment opportunity

On July 23, President Iván Duque signed a decree authorizing the export of dried cannabis flowers for medicinal purposes in order to provide more incentives to the country’s pharmaceutical industry and guarantee access to medicines derived from the plant.

The decree also seeks to encourage the market for medical cannabis, as well as its use in scientific, medicinal, and industrial research to promote the country’s economic reactivation, job creation, and industrial development.

It also allows the transfer of cannabis to free trade zones so that it can be cut, dried, transformed, and packaged.

__

(Featured image by CRYSTALWEED Cannabis via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in La Jornada, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.